PMC7495166_01
HR-CT findings on day 1 with few focal ground-glass opacifications (GGO), day 9 with GGO dissemination, and day 16 with substantial improvement of the lung parenchyma.
CRIID2020-8830626.001.jpg
PMC7495166_01_CRIID2020-8830626.001.jpg
fig1
A nasopharyngeal COVID swab was done followed by an HR-CT of the chest which revealed bilateral round-shape ground-glass opacifications in both lungs showing peripheral distribution in favor of COVID-19 pneumonia (Figure 1, day 1). A repeated HR-CT revealed worsening of chest findings (Figure 1, day 9). We therefore decided to give a single shot of tocilizumab 400 mg intravenously and start the patient on Kaletra (lopinavir/ritonavir) and prednisolone 10 mg daily (Figure 1). On day 16, HR-CT was repeated and showed almost complete clearance of the previous lesions (Figure 1, day 16).